Zhejiang Medicine first-half net profit attributable to parent falls 9.99% to 606 million yuan

央广财经··CN·Read original
2▲0 ▼1Impact / 5
Summary · why it matters

Zhejiang Medicine disclosed its 2026 semi-annual report. In the first half, it achieved operating revenue of 4.386 billion yuan, up 1.46% year on year. Net profit attributable to shareholders of the listed company was 606 million yuan, down 9.99% year on year.

Impact on assets 1

Others▼ · 1 stocks
© 2026 MarketIVNews